CAR T cell viability release testing and clinical outcomes: is there a lower limit?

Blood. 2019 Nov 21;134(21):1873-1875. doi: 10.1182/blood.2019002258.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cell Survival*
  • Humans
  • Immunotherapy, Adoptive / standards*
  • Lymphoma, Large B-Cell, Diffuse / mortality
  • Lymphoma, Large B-Cell, Diffuse / therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Receptors, Antigen, T-Cell / therapeutic use*
  • Receptors, Chimeric Antigen
  • T-Lymphocytes*
  • Treatment Outcome

Substances

  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen
  • tisagenlecleucel